Pelvic Inflammatory Disease Management (CDC 2021)
Pelvic Inflammatory Disease Management (CDC 2021): Suspected PID → Diagnostic Criteria → Diagnostic Workup → Severity Assessment → Inpatient Criteria.
Interactive Decision Tree
Algorithm Steps
- ▶Start
Suspected PID
Lower abdominal/pelvic pain in sexually active patient
- ●Action
Diagnostic Criteria
Minimum criteria for empiric treatment
- MINIMUM CRITERIA (any one):
- - Cervical motion tenderness
- - Uterine tenderness
- - Adnexal tenderness
- ADDITIONAL CRITERIA (support diagnosis):
- - Temp >38.3°C (101°F)
- - Mucopurulent cervical discharge
- - WBC on wet prep
- - Elevated ESR or CRP
- - Lab evidence of GC or chlamydia
- ●Action
Diagnostic Workup
Rule out emergencies, obtain cultures
- Pregnancy test (rule out ectopic)
- NAAT for GC and chlamydia
- Wet prep/vaginal microscopy
- HIV testing
- Consider: CBC, CRP, urinalysis
- Pelvic ultrasound if TOA suspected
- ◆Decision
Severity Assessment
Inpatient vs outpatient management
- ●Action
Inpatient Criteria
Admit if any present
- Surgical emergency not excluded (appendicitis, ectopic)
- Pregnant
- Unable to tolerate oral meds (N/V)
- Severe illness, high fever, peritonitis
- Tubo-ovarian abscess
- Failed outpatient therapy
- ●Action
Inpatient IV Treatment
Parenteral regimens
- REGIMEN A:
- Ceftriaxone 1g IV q24h + Doxycycline 100mg IV/PO q12h + Metronidazole 500mg IV/PO q12h
- REGIMEN B:
- Cefoxitin 2g IV q6h + Doxycycline 100mg IV/PO q12h
- Transition to oral after 24-48h improvement
- ●Action
Follow-Up
Essential for all patients
- 72-hour follow-up for clinical improvement
- Partner treatment (expedited partner therapy)
- STI counseling and education
- Retest for GC/chlamydia in 3 months
- Counsel on fertility implications
- ✓Outcome
Resolution
Complete antibiotic course, test of cure
- ●Action
Outpatient Treatment
CDC 2021 recommended regimen
- Ceftriaxone 500mg IM x1 (1g if ≥150kg)
- PLUS Doxycycline 100mg PO BID x 14 days
- PLUS Metronidazole 500mg PO BID x 14 days
- Alternative cephalosporin + probenecid options available
- Follow-up in 72 hours essential
- ⚠Warning
Partner Notification
All sex partners in past 60 days
- Evaluate and treat presumptively
- Expedited partner therapy if allowed
- Abstain from intercourse until treatment complete
- ◆Decision
Tubo-Ovarian Abscess?
Ultrasound or clinical suspicion
- ●Action
TOA Management
May require drainage
- IV antibiotics initially
- Consider interventional drainage if >6-8cm
- Surgical management if ruptured
- Follow with imaging for resolution
- May require prolonged antibiotics
Guideline Source
CDC Sexually Transmitted Infections Treatment Guidelines 2021
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- PID is a clinical diagnosis - no gold standard test
- Treatment empiric - culture results take days
- Partner notification essential
- Tubo-ovarian abscess requires additional management
Applicable Regions
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Pelvic Inflammatory Disease Management (CDC 2021)?
The Pelvic Inflammatory Disease Management (CDC 2021) is a management clinical algorithm for Obstetrics & Gynecology. It provides a structured decision tree to guide clinical decision-making, based on CDC Sexually Transmitted Infections Treatment Guidelines 2021.
What guideline is the Pelvic Inflammatory Disease Management (CDC 2021) based on?
This algorithm is based on CDC Sexually Transmitted Infections Treatment Guidelines 2021 (DOI: 10.15585/mmwr.rr7004a1).
What are the limitations of the Pelvic Inflammatory Disease Management (CDC 2021)?
Known limitations include: PID is a clinical diagnosis - no gold standard test; Treatment empiric - culture results take days; Partner notification essential; Tubo-ovarian abscess requires additional management. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Pelvic Inflammatory Disease Management (CDC 2021) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free